Search results for: Real World Evidence (RWE)
Filter search results
Cost Savings from Treating Obstructive Sleep Apnoea: OHE Consulting Report
26 September 2014
…for milder cases, is inconclusive at this point. Despite the clear evidence of benefit, the report notes that recent research estimates that about 85% of OSA cases currently are undiagnosed…
New Publication: Spillovers between Public and Private Sector Biomedical and Health Research
8 March 2016
…UK on the UK economy. This implies a real annual rate of return (in terms of GDP impact) to public biomedical and health research in the UK of around 17%…
OHE at AES 2016: Early Access Schemes, Equity Adjusted QALYs, Multi-indication Pricing and Formulary Development
2 August 2016
…patients with high unmet medical need and to incentivise innovation and R&D. Berdud and colleagues model existing early access and adaptive pathway policies for a real case study. They assess…
OHE at Priorities 2016: Valuing Health at the End of Life and MCDA for Priority Setting
19 September 2016
…by Rob Baltussen, with Mireille Goetghebeur (University of Montreal) and Norman Daniels (Harvard School of Public Health) as contributors. The session: provided an overview on the use of multi-criteria decision…
Presentations and Posters from ISPOR Europe 2016
24 November 2016
…Sachin Kamal-Bahl (Pfizer), Alastair Kent (Genetic Alliance UK). During this session panellists debated how addressing payer and patient interests simultaneously could impact research functions, including broader evidence generation, patient-reported outcomes…
OHE at ISPOR Boston 2017: Presentations and Posters
4 July 2017
…there is a case for systematically considering evidence patient preferences as part of HTA processes. However, ultimately HTA decisions involve weighing up both benefits to patients affected by the technology…
OHE is Pleased to Announce the Appointment Two New Economists: Marina Rodes Sanchez and Chris Sampson
12 October 2017
…the Universitat Pompeu Fabra, which included a semester spent as a visiting student at HEC Montréal. Chris Sampson joins OHE from the University of Nottingham where he has worked as…
OHE Lunchtime Seminar: Is Hypothecation the Way to Raise the Money for the “multi-year” Funding Settlement That the NHS Has Been Promised?
4 July 2018
…services averaging 3.4% per year growth in real terms funding. But she has yet to spell out how the money for that will be raised. In recent months, there has…
Assessing the Life-cycle Value of Second-generation Antipsychotics in Sweden and the UK
17 July 2019
…M. and Towse, A., 2017. What do pharmaceuticals really cost in the long run? The American Journal of Managed Care, 23(8), pp.488–493. Lindgren, P. and Jönsson, B., 2012. Cost–effectiveness…